Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Treating TRK fusion cancer: Selecting between available agents

Prof Marc Peeters and Dr David Hong
Treating TRK fusion cancer: Selecting between available agents ( Prof Marc Peeters and Dr David Hong )
3 Apr 2020

CARTs for the treatment of T-cell malignancies

Dr John DiPersio - Siteman Cancer Center, St. Louis, USA
CARTs for the treatment of T-cell malignancies ( Dr John DiPersio - Siteman Cancer Center, St. Louis, USA )
1 Apr 2020

Testing and treatment for CDH1 in hereditary diffuse gastric cancer and breast cancer

Dr. Geraldo Alves - Hospital Santa Rosa, Brasil
Testing and treatment for CDH1 in hereditary diffuse gastric cancer and breast cancer ( Dr. Geraldo Alves - Hospital Santa Rosa, Brasil )
26 Mar 2020

Haematological malignancies: Latest advances from ASH 2019

Dr Eloísa Riva - Hospital de Clínicas, Montevideo, Uruguay
Haematological malignancies: Latest advances from ASH 2019 ( Dr Eloísa Riva - Hospital de Clínicas, Montevideo, Uruguay )
10 Mar 2020

Updates in treating NTRK fusion cancer: Highlights from ESMO 2019

Prof Marc Peeters and Prof Jesus Garcia-Foncillas
Updates in treating NTRK fusion cancer: Highlights from ESMO 2019 ( Prof Marc Peeters and Prof Jesus Garcia-Foncillas )
9 Mar 2020

Management of mutation-negative NSCLC

Dr Vijay Patil - Tata Medical Center, Kolkata, India
Management of mutation-negative NSCLC ( Dr Vijay Patil - Tata Medical Center, Kolkata, India )
6 Mar 2020

Management of advanced cervical cancer

Dr Avinash Pandey - State Cancer Institute, Patna, India
Management of advanced cervical cancer ( Dr Avinash Pandey - State Cancer Institute, Patna, India )
6 Mar 2020

Systematic therapy of driver mutated NSCLC

Dr Vijay Patil - Tata Medical Center, Kolkata, India
Systematic therapy of driver mutated NSCLC ( Dr Vijay Patil - Tata Medical Center, Kolkata, India )
6 Mar 2020

KEYNOTE 199 cohorts 4 & 5: Enzalutamide and pembrolizumab for mCRPC

Dr Julie Graff - Oregon Health & Science University, Portland, USA
KEYNOTE 199 cohorts 4 & 5: Enzalutamide and pembrolizumab for mCRPC ( Dr Julie Graff - Oregon Health & Science University, Portland, USA )
19 Feb 2020

Integrative molecular characterisation of S/R RCC to reveal determinants of poor prognosis and response to ICIs

Dr Ziad Bakouny - Dana-Farber Cancer Institute, Boston, USA
Integrative molecular characterisation of S/R RCC to reveal determinants of poor prognosis and response to ICIs ( Dr Ziad Bakouny - Dana-Farber Cancer Institute, Boston, USA )
18 Feb 2020

Cytoreductive nephrectomy for mRCC treated with immune checkpoint inhibitors or targeted therapy

Dr Ziad Bakouny - Dana-Farber Cancer Institute, Boston, USA
Cytoreductive nephrectomy for mRCC treated with immune checkpoint inhibitors or targeted therapy ( Dr Ziad Bakouny - Dana-Farber Cancer Institute, Boston, USA )
18 Feb 2020

NEO-BLADE: Nintedanib or placebo with gemcitabine and cisplatin in locally advanced muscle invasive bladder cancer

Dr Syed Hussain - University of Sheffield, Sheffield, United Kingdom
NEO-BLADE: Nintedanib or placebo with gemcitabine and cisplatin in locally advanced muscle invasive bladder cancer ( Dr Syed Hussain - University of Sheffield, Sheffield, United Kingdom )
18 Feb 2020